For example, controlled trials in diabetic polyneuropathy have employed 600 mg of ALA injected IV once daily (often given as an infusion over 30-60 minutes) for periods of 2-4 weeks, with significant efficacy observed in reducing neuropathic symptoms compared to placebo
The growing investments for the development of structure-based drugs and technological advancements by both public and private research organizations are driving the demand for protein purification, in turn, making the protein purification application the dominant application segment and driving the product demand
Supports a healthy GI system*
Shrestha B, Reed JM, Starks PT, Kaufman GE, Goldstone JV, Roelke ME, et al
It is a vicious cycle
Our team treats common illnesses such as flu and COVID, providing quick evaluation, testing guidance, and prescriptions when needed